TC |
Stat |
Stk |
Ins |
Fil |
+d |
+w |
+m |
+q |
+h |
+y |
avg |
|---|
Filing Date |
T Date |
Ticker |
Issuer | Inc | Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
2/15/24 16:01 | 2/13/24 | MRK | Merck & Co., Inc. | NJ | Health | Drug | Pharmaceutical Preparations | Davis Robert M | NJ | DO | CB,CEO,P | M.dm | 17,396 | 74.02 | 0 | 235 | 207 | 348 | D | ||||||||||||||
2/15/24 16:01 | 2/13/24 | MRK | Merck & Co., Inc. | NJ | Health | Drug | Pharmaceutical Preparations | Davis Robert M | NJ | DO | CB,CEO,P | S.dm | -29,539 | 125.69 | 0 | -235 | -40 | 348 | D | ||||||||||||||
4/28/23 17:15 | 4/28/23 | MRK | Merck & Co., Inc. | NJ | Health | Drug | Pharmaceutical Preparations | Davis Robert M | NJ | DO | CB,CEO,P | M.d | 8,032 | 56.04 | 0 | 143 | 112 | 272 | D | ||||||||||||||
4/28/23 17:15 | 4/28/23 | MRK | Merck & Co., Inc. | NJ | Health | Drug | Pharmaceutical Preparations | Davis Robert M | NJ | DO | CB,CEO,P | S.d | -16,473 | 114.93 | 0 | -143 | -35 | 272 | D | ||||||||||||||
11/10/22 16:42 | 11/9/22 | MRK | Merck & Co., Inc. | NJ | Health | Drug | Pharmaceutical Preparations | Davis Robert M | NJ | DO | CEO,P | M.d | 0 | 0.00 | 0 | 168 | 210 | 248 | D | ||||||||||||||
11/10/22 16:42 | 11/9/22 | MRK | Merck & Co., Inc. | NJ | Health | Drug | Pharmaceutical Preparations | Davis Robert M | NJ | DO | CEO,P | S.d | -17,170 | 102.44 | 0 | -168 | -40 | 248 | D |
| D | Derivative transaction in filing (usually option exercise) |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| A | Amended filing |
| E | Error detected in filing |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |